
1. General Information
INVISTA is a prescription anti-cancer medicine containing Dasatinib, a targeted therapy belonging to the class of medicines known as tyrosine kinase inhibitors (TKIs). Dasatinib is primarily used in the treatment of certain types of blood cancers, particularly Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL).
Dasatinib works by blocking abnormal proteins responsible for signaling cancer-cell growth and multiplication. It is generally prescribed and monitored by an oncologist or hematologist.
Important: Invista listings found in current pharmaceutical sources show strengths such as 50 mg, 70 mg and 100 mg. The stated 500 mg strength should be verified with the product packaging/manufacturer before listing or supplying.
2. Product Information
Brand Name: Invista
Active Ingredient: Dasatinib
Drug Class: Tyrosine Kinase Inhibitor
Therapeutic Category: Anti-Cancer / Oncology Medicine
Dosage Form: Tablet
Commonly Listed Strengths: 50 mg, 70 mg and 100 mg
Manufacturer commonly associated with Invista: Dr. Reddy's Laboratories
Prescription Status: Prescription medicine
Primary Treatment Area: Certain blood cancers, including CML and Ph+ ALL
3. Uses of INVISTA
Dasatinib may be prescribed for:
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
Certain cases of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
Newly diagnosed Ph+ CML in the chronic phase
CML or ALL when previous treatment has not provided an adequate response or is not tolerated
The exact indication and treatment regimen depend on the patient's diagnosis, age, previous treatment and clinical condition.
4. Benefits of INVISTA
When prescribed appropriately, dasatinib can provide the following therapeutic benefits:
Helps control abnormal growth of leukemia cells
Targets specific cancer-driving tyrosine kinase proteins
Can be used in certain Ph+ leukemia treatment protocols
Provides a targeted treatment approach rather than acting as a conventional nonspecific chemotherapy medicine
May be useful when some other leukemia treatments are ineffective or poorly tolerated
Treatment response varies between patients and should be evaluated through regular medical follow-up and laboratory testing.
5. Side Effects of INVISTA
Like other anti-cancer medicines, dasatinib can cause side effects. Some may be mild, while others require immediate medical attention.
Possible side effects include:
Low blood cell counts
Anemia
Reduced platelet count
Reduced white blood cell count
Headache
Nausea
Diarrhea
Vomiting
Skin rash
Fatigue
Muscle or joint pain
Fluid retention
Dasatinib can also cause serious complications such as bleeding, severe reduction in blood-cell counts, fluid around the lungs, heart-related problems and other significant reactions. Patients should remain under appropriate medical supervision.
6. Common Side Effects
Some commonly reported effects may include:
Headache
Nausea
Diarrhea
Vomiting
Tiredness
Muscle or joint discomfort
Skin rash
Abdominal discomfort
Changes in blood-cell counts
Contact a healthcare professional if side effects become persistent, severe or unusual.
7. How to Use INVISTA
Take INVISTA exactly according to the dosage and schedule prescribed by your doctor.
General administration guidance includes:
Take the tablet at approximately the same time each day.
Swallow the tablet whole with water.
Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.
It may generally be taken with or without food according to the prescribed instructions.
Do not change the dose or stop treatment without consulting your doctor.
If a dose is missed, follow your healthcare professional's instructions rather than taking an additional dose on your own.
Because dasatinib is a potent prescription oncology medicine, the dosage should be individualized by the treating specialist.
8. How INVISTA Works
INVISTA contains dasatinib, which works by inhibiting specific tyrosine kinases involved in the growth and survival of abnormal leukemia cells.
In Ph+ leukemia, abnormal BCR-ABL signaling plays an important role in uncontrolled cancer-cell growth. Dasatinib blocks BCR-ABL and other relevant kinase activity, thereby interfering with signals that encourage leukemia cells to multiply.
This targeted mechanism helps control the abnormal cells responsible for the disease.
9. Safety Advice for INVISTA
Use only under the supervision of a qualified oncologist or hematologist.
Regular blood tests may be required to monitor blood-cell counts.
Inform your doctor about all medicines, supplements and herbal products you take.
Tell your doctor if you have a history of heart problems, bleeding disorders, liver problems or lung problems.
Avoid grapefruit and grapefruit juice unless your healthcare professional specifically advises otherwise, as they may increase dasatinib exposure.
Seek urgent medical attention for unusual bleeding, severe breathing difficulty, chest pain, fainting or signs of serious infection.
Do not discontinue cancer treatment suddenly without medical advice.
Pregnant or breastfeeding patients should discuss treatment with their doctor before using dasatinib.
Keep the medicine out of the reach of children.
Store according to the manufacturer's instructions.
10. FAQ's
Q1. What is INVISTA used for?
INVISTA contains dasatinib and is used to treat certain Philadelphia chromosome-positive blood cancers, including CML and Ph+ ALL.
Q2. What is the active ingredient in INVISTA?
The active ingredient is Dasatinib.
Q3. Is INVISTA a chemotherapy medicine?
Dasatinib is an anti-cancer medicine, but it is specifically classified as a targeted tyrosine kinase inhibitor rather than traditional nonspecific chemotherapy.
Q4. Can INVISTA be taken without a prescription?
No. Dasatinib is a prescription oncology medicine and should be used only under appropriate medical supervision.
Q5. What are the common side effects?
Headache, nausea, diarrhea, vomiting, fatigue, rash and changes in blood-cell counts can occur.
Q6. Can I stop INVISTA when I feel better?
No. Do not stop dasatinib without discussing it with your treating doctor.
Q7. Does INVISTA require regular blood tests?
Yes. Doctors commonly monitor blood counts and other relevant parameters during treatment.
Q8. Can INVISTA interact with other medicines?
Yes. Dasatinib can interact with several medicines, so inform your doctor about all prescription, OTC and herbal products you use.
Q9. Is INVISTA 500 mg available?
The pharmaceutical sources reviewed list Invista primarily in 50 mg, 70 mg and 100 mg strengths. Therefore, the claimed 500 mg strength should be verified against the original product packaging and manufacturer information before publication.
Q10. Who should prescribe INVISTA?
Treatment should be determined by an oncologist or another appropriately qualified healthcare professional experienced in managing leukemia.
11. Substitute for INVISTA
Potential substitutes for dasatinib should contain the same active ingredient, strength and appropriate dosage form, but the exact substitute depends on the patient's prescription and treatment plan.
Examples of dasatinib products may include:
Generic Dasatinib Tablets
Dasatinib tablets from other approved manufacturers
Other branded dasatinib products
Do not replace INVISTA with another anti-cancer medicine without approval from the treating oncologist. Different leukemia medicines are not automatically interchangeable.
12. SEO Keywords
Invista 500 mg tablets supplier from India
Invista tablets exporter from India
Dasatinib tablets supplier India
Dasatinib medicine exporter
Invista Dasatinib tablets India
Anti cancer medicine exporter India
Leukemia medicine supplier from India
CML treatment medicine supplier
Dasatinib tablets wholesale supplier
Invista medicine export from India
Dasatinib pharmaceutical exporter
Generic Dasatinib tablets supplier
Invista tablets global supplier
Blood cancer medicine exporter India
Ph+ leukemia medicine supplier
Dasatinib CML medicine exporter
Oncology medicine supplier India
Prescription cancer medicine exporter
Invista medicine supplier USA
Invista medicine supplier UK
Invista medicine supplier Australia
Invista medicine supplier Canada
Invista medicine supplier Singapore
Invista medicine supplier South Korea
Invista medicine supplier UAE
Dasatinib exporter to USA
Dasatinib exporter to UK
Dasatinib exporter to Australia
Dasatinib exporter to Canada
Dasatinib exporter to Singapore
Dasatinib exporter to South Korea
Dasatinib exporter to UAE
Indian pharmaceutical medicine exporter
Phoenix Exim oncology medicine supplier
Phoenix Exim global pharmaceutical exporter
Keywords







